Bloom Burton

//Bloom Burton

Medicenna Announces Closing of Public Offering of $6,900,000

By | October 17th, 2019|Bloom Burton, Financing, News|

Medicenna Announces Closing of Public Offering of $6,900,000 Original press [...]

BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States

By | September 9th, 2019|Bloom Burton, Financing, News|

BELLUS Health Closes US$70 Million Public Offering of Common Shares [...]

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

By | August 27th, 2019|Bloom Burton, Financing, News|

ESSA PHARMA COMPLETES PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT FOR [...]

Antibe Announces Closing of Public Offering

By | August 13th, 2019|Bloom Burton, Financing, News|

Antibe Announces Closing of Public Offering Original press release here [...]

Three Finalists Announced for the 2019 Bloom Burton Award

By | May 7th, 2019|Bloom Burton, News|

Three Finalists Announced for the 2019 Bloom Burton Award Award [...]

The Science of Commercialization

By | January 30th, 2019|Bloom Burton, News|

November 8, 2018; Hamilton, Ontario, Canada; Triumvira is a [...]

Greenbrook TMS Announces Closing of Private Placement Totaling USD $20,000,000

By | June 7th, 2018|Bloom Burton, Financing, News|

Toronto, ON — June 7, 2018 — Greenbrook TMS, the largest provider [...]

CannTrust™ Announces Closing of $100,395,000 Bought Deal

By | June 5th, 2018|Bloom Burton, Financing, News|

VAUGHAN, ON, June 5, 2018 /CNW/ – CannTrust Holdings Inc. (TSX: TRST) (“CannTrust” [...]

Bloom Burton & Co. Welcomes Michael J. Brown, CFA® as Portfolio Manager and Chief Executive Officer of its Asset Management Affiliate, Bloom Burton Investment Group.

By | May 30th, 2018|Bloom Burton, News|

TORONTO, May 30, 2018 – Bloom Burton & Co. (“Bloom [...]

Immunovaccine Announces Closing of CAD$14,375,000 Bought Deal Offering with Over-Allotment Option Exercised in Full

By | March 6th, 2018|Bloom Burton, Financing, News|

HALIFAX, N.S., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. [...]